Sign in
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Monday, December 23, 2024
Sign in / Join
Facebook
Instagram
Twitter
Vimeo
Youtube
Pharma Deals
Update
Oncology
Search
LATEST ARTICLES
Collaboration agreement
Gilead-Tentarix Collaborates to Develop Cancer and Inflammation Therapy for $66M
pharmaquotient.com
-
15 August 2023
0
generic
Sandoz Announces Positive Results for Biosimilar Aflibercept
pharmaquotient.com
-
15 August 2023
0
Merger & Acquisition
Lilly Acquired Sigilon Therapeutics
pharmaquotient.com
-
14 August 2023
0
Regulatory update
JNJ Expands Cancer Portfolio with TALVEY Approval
pharmaquotient.com
-
10 August 2023
1
Clinical update
Novartis’ Remibrutinib Improves symptom in chronic spontaneous urticaria
pharmaquotient.com
-
9 August 2023
0
Oncology
Astellas invested $50 M in Poseida’s CAR-T Cell Therapy for Cancer
pharmaquotient.com
-
8 August 2023
0
Business Strategy
Daiichi Sankyo Decided for RD Novare Closure
pharmaquotient.com
-
7 August 2023
0
Weekly News Updates
Weekly News for the Week Ending 5-August-2023
pharmaquotient.com
-
6 August 2023
0
Update
US FDA Approves Zurzuvae For Postpartum Depression
pharmaquotient.com
-
4 August 2023
1
Regulatory update
U.S. FDA Approves Merck’s ERVEBO®
pharmaquotient.com
-
3 August 2023
0
1
...
4
5
6
7
Page 5 of 7
Most Popular
Neuralink’s Blindsight: A Breakthrough in Vision Restoration
20 September 2024
Theratechnologies Indicated Potential Supply Disruption for EGRIFTA SV® in Early 2025
17 September 2024
Kissei Pharmaceuticals Enters into a Drug discovery research collaboration agreement with Reborna Biosciences.
9 September 2024
Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
7 September 2024
Load more
Recent Comments
Rahul
on
US FDA Approves Zurzuvae For Postpartum Depression
Rahul
on
JNJ Expands Cancer Portfolio with TALVEY Approval
Ashish
on
Flagship Pioneering Partners with Pfizer to Bolster Development of Innovative Medicine for $50M upfront
Recent Comments